Virios Therapeutics, Inc.
VIRI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15,745 | -$3,807 | -$10,925 | -$12,346 |
| Dep. & Amort. | $2 | $0 | $52 | $71 |
| Deferred Tax | -$1 | $0 | $191 | -$1 |
| Stock-Based Comp. | $48 | $65 | $84 | $476 |
| Change in WC | $0 | $0 | $0 | $0 |
| Other Non-Cash | $12,423 | -$284 | $5,915 | $3,013 |
| Operating Cash Flow | -$3,273 | -$4,026 | -$4,683 | -$8,788 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $3,762 |
| Investing Cash Flow | $0 | $0 | $0 | $3,762 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | -$120 | $4,372 | $1,380 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | -$1,257 | -$514 |
| Other Fin. Act. | $0 | -$120 | $8,629 | $17,215 |
| Financing Cash Flow | $0 | -$120 | $7,372 | $16,701 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,276 | -$4,136 | $2,691 | $14,845 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,403 | $17,539 | $14,848 | $3 |
| End Cash | $10,127 | $13,403 | $17,539 | $14,848 |
| Free Cash Flow | -$3,273 | -$4,026 | -$4,683 | -$8,788 |